Brief: Conmed Q4 sales USD 250.867 million
02/02/2023 22:34
Feb 2 (Reuters) - Conmed Q4 sales USD 250.867 million. * Q4 pretax profit USD -10.538 million * Q4 net income USD 26.584 million * Q4 EPS USD 0.86 * Outlook FY revenue USD 1,170-1,220 million * Outlook FY adjusted EPS USD 3.2-3.45
Recent news on Conmed
See all newsBrief: Conmed Enters Agreements To Repurchase 2.25% Convertible Senior Notes Due 2027 On June 3 - SEC Filing
Brief: Conmed Enters First Omnibus Amendment And Increased Facility Activation Notice On May 27, 2026 - SEC Filing
Brief: Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors
Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance
Brief: Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED